GlobeNewswire by notified

Ace Group International / Atelier Ace Enters Agreement to Join Sortis Holdings, Inc.


Recent openings by the ground-breaking hospitality group include locations in Kyoto, Sydney, Brooklyn and Toronto

NEW YORK, Jan. 25, 2023 (GLOBE NEWSWIRE) -- Ace Group International — the trailblazing hospitality company responsible for hotel brands Ace Hotel, Maison de la Luz and Sister City — has entered into an agreement to be acquired by innovative hospitality platform Sortis Holdings, Inc. The transaction is expected to close at the end of Q1 2023, subject to customary closing conditions. 

The Sortis acquisition of Ace Group International comes on the heels of a fast-paced few years for the brand. Ace’s evolution has remained constant, with the brand having opened award-winning hotels in new markets including Japan (Ace Hotel Kyoto, opened 2020), Australia (Ace Hotel Sydney, 2022) and Canada (Ace Hotel Toronto, also in 2022). The brand also spearheaded the opening of a sister property to its iconic Manhattan hotel, Ace Hotel New York, with the Ace Hotel Brooklyn outpost opening in Boerum Hill in 2021. 

We are appreciative of the warm reception to the brand’s recent openings in Kyoto, Brooklyn, Sydney and Toronto, and take pride in having expanded from our humble beginnings in Seattle to a global company spanning four continents. We could not be more excited to partner with Sortis — a like-minded organization that will support the innovation and mold-breaking that Ace has long been known for, as well as facilitate growth. We have a strong pipeline of new projects, both domestic and international, and we look forward to continuing to share our vision of hospitality with the world.” – Brad Wilson, C.E.O., Ace Group International / Atelier Ace 

“During a period of great turbulence in our industry, and the world more broadly, we have been continually inspired and fortified by the strength and dedication of the Ace team globally. In addition to our successful openings over the past several years, and the recent announcement of our partnership with noma at Ace Hotel Kyoto, our team has continued to uphold the core mission set by our founders more than 20 years ago — to challenge the status quo, support artists and creatives of all stripes, and create friendly places for both locals and visitors to feel welcome in. Brad and I look forward to expanded opportunities, with the added resources and expertise that Sortis will bring to the table.” – Meriem Soliman, President, Ace Group International / Atelier Ace 

Brad Wilson will remain in the role of Chief Executive Officer, and Ace Group International will become a wholly owned subsidiary of Sortis. Sortis and Ace plan to maintain the Atelier Ace team, and the acquisition will bring additional properties under Ace management.

Ace was founded in Belltown, Seattle in 1999, and has since expanded to include 10 locations globally — Portland, New York, Palm Springs, Los Angeles, New Orleans, Kyoto, Brooklyn, Sydney and Toronto. Atelier Ace, the in-house creative studio at Ace, also developed Maison de la Luz, a 67-room luxury guesthouse in New Orleans, and the distilled-service brand Sister City. 

About Ace Hotel:

Ace Hotel reimagines urban spaces for people who make cities interesting. Our approach to all our projects is simple — we seek to genuinely embrace local culture in the areas we inhabit. We bring together narratives, artists and materials that speak to the building, to the site and to the city. From there, we welcome in the alchemy that’s created.

Our worlds are vast and dynamic. We build relationships with a wide range of people — makers, thinkers, creative do-it-yourselfers in the fields of art, technology, music, fashion, media and gastronomy. We are curious about the history and geography of the buildings and neighborhoods we inhabit, and let these learnings guide us to someplace new. By honoring the architectural and social history of a site, with an eye towards the future that envisions respectful and nuanced dedication to a community, we create inspired spaces full of local art, intentional design and curious possibilities.

About Sortis Holdings, Inc.: 

From award-winning hospitality to cult coffee to the world’s first sustainable sushi bar, Sortis Holdings is an ecosystem of idiosyncratic brands that live at the intersection of radical vision, cultural relevance and expansive potential. Through decades’ worth of seasoned market acumen, intuitive brand development and creative business strategy, we empower brands to become more of themselves, amplifying unique voices and moving culture forward in the process.

To view this piece of content from, please give your consent at the top of this page.
To view this piece of content from, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Galapagos announces topline results from Phase 3 DIVERSITY trial of filgotinib in Crohn’s disease8.2.2023 22:01:00 CET | Press release

The two induction cohorts missed the co-primary endpoints of clinical remission and endoscopic response at Week 10In the maintenance phase, filgotinib 200mg once daily achieved the co-primary endpoints of clinical remission and endoscopic response at Week 58The safety findings were generally consistent with the known profile of filgotinib in rheumatoid arthritis (RA) and ulcerative colitis (UC)Galapagos decided not to submit a Marketing Authorization Application in Europe based on these topline dataGalapagos remains fully committed to filgotinib, a JAK1 preferential inhibitor orally administered once daily, and its approved indications, RA and UC, and is on track to start a Phase 3 trial in axial spondyloarthritis (AxSpA) later this year Mechelen, Belgium; 8February2023, 22:01CET; regulated information; Galapagos NV (Euronext & NASDAQ: GLPG) todayannouncedthe topline results from DIVERSITY,a global Phase 3 trial to evaluate the safety and efficacy of filgotinib,100mg or 200mg once dail

X8 AG Submits a Swiss Fintech Licence Application8.2.2023 21:21:16 CET | Press release

X8 AG submitted the application for a Swiss FinTech license according to Art. 1b Banking Act with the intention of operating a regulated global stablecoin system BAAR, Switzerland, Feb. 08, 2023 (GLOBE NEWSWIRE) -- The X8 AG team has successfully submitted the application to FINMA, the Swiss Financial Market Supervisory Authority, for the Swiss FinTech license according to Article 1b Banking Act. This marks an important step for X8 AG on its way to become a fully regulated global stablecoin system and significantly differentiating itself from the current non-regulated crypto space. Switzerland offers one of the most advanced regulatory frameworks for digital assets. X8 AG believes that designing its stablecoin system under Swiss law is the best starting point to achieve a global X8 cross-border framework for payments. Full compliance with the Swiss regulatory framework strengthens the high standards of protection for clients. X8 AG aims to empower users and their money with frictionles

GN Store Nord announces intention to initiate a rights issue8.2.2023 20:08:16 CET | Press release

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, AUSTRALIA, JAPAN OR ANY OTHER JURISDICTION WHERE THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL This announcement does not constitute an offering memorandum or a prospectus as defined by Regulation (EU) No. 2017/1129 of 14 June 2017. The offer to acquire securities pursuant to the offering is made, and any investor should make their investment decision, solely on the basis of information that is contained in the prospectus to be made generally available in Denmark in connection with the offering. GN Store Nord announces intention to initiate a rights issue In accordance with our announcement on November 11, 2022, GN has conducted a comprehensive review of the appropriate capital structure. In light of the current macroeconomic environment and GN’s leverage, GN announces today that it intends to raise gross proceeds of DKK 7 billion in the first half

Nokia Corporation: Repurchase of own shares on 08.02.20238.2.2023 20:00:00 CET | Press release

Nokia Corporation Stock Exchange Release 8 February 2023 at 21:00 EET Nokia Corporation: Repurchase of own shares on 08.02.2023 Espoo, Finland – On 8 February 2023 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired its own shares (ISIN FI0009000681) as follows: Trading venue (MIC Code)Number of sharesWeighted average price / share, EUR*XHEL282,2294.39CEUX20,3804.39AQEU6,3784.39TQEX5,0134.38Total314,0004.39 * Rounded to two decimals On 3 February 2022, Nokia announced that its Board of Directors is initiating a share buyback program under the authorization granted by Nokia’s Annual General Meeting on 8 April 2021 to return up to EUR 600 million of cash to shareholders in tranches over a period of two years. The second phase of the share buyback program in compliance with the Market Abuse Regulation (EU) 596/2014 (MAR), the Commission Delegated Regulation (EU) 2016/1052 and under the authorization granted by Nokia’s Annual General Meeting on 5 April 2022 started on 2 January 2023

Interim report 2022/23 - 15% revenue growth and DKK 145 million operating profit (+25%) for the first half following a challenging second quarter8.2.2023 18:57:07 CET | Press release

ANNOUNCEMENT NO. 234 9 February 2023 Interim report for the first half of 2022/23 15% revenue growth and DKK 145 million operating profit (+25%) for the first half following a challenging second quarter Steen Søndergaard, CEO: “Following a very satisfactory 2021/22 with historically high revenue and operating profit growth rates, revenue for the first half of 2022/23 unfortunately disappointed, despite 15% growth. Second quarter sales of instruments, particularly in the North American market, were challenged by a generally more subdued investment sentiment in our primary business segment, cell-based therapy. Our order intake was mainly impacted by weakened demand from capital-sensitive development companies. On the other hand, we saw continued satisfactory growth in sales of consumables and services. Despite the unfavourable market conditions, our earnings continued to grow. While our market is currently affected by the prevailing macroeconomic environment, we have a strong underlying